Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis

Objective: To evaluate the safety and cardiovascular effect of low-dose spironolactone administration in end-stage renal failure patients undergoing hemodialysis coupled with conventional treatment. Methods: We conducted a systematic search for clinical trials on the safety and cardiovascular effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qing, Zhou, XiaoDuo, Xu, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504555/
https://www.ncbi.nlm.nih.gov/pubmed/31118582
http://dx.doi.org/10.2147/DDDT.S189454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504555/
https://www.ncbi.nlm.nih.gov/pubmed/31118582
http://dx.doi.org/10.2147/DDDT.S189454

Ejemplares similares